- Home
- ALDX vs NNOX Comparison
ALDX vs NNOX Comparison
Compare ALDX & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- NNOX
- Stock Information
- Founded
- ALDX 2004
- NNOX 2011
- Country
- ALDX United States
- NNOX Israel
- Employees
- ALDX N/A
- NNOX N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- ALDX Health Care
- NNOX Health Care
- Exchange
- ALDX Nasdaq
- NNOX Nasdaq
- Market Cap
- ALDX 313.4M
- NNOX 253.8M
- IPO Year
- ALDX 2014
- NNOX 2020
- Fundamental
- Price
- ALDX $5.26
- NNOX $3.99
- Analyst Decision
- ALDX Strong Buy
- NNOX Strong Buy
- Analyst Count
- ALDX 2
- NNOX 2
- Target Price
- ALDX $9.50
- NNOX $8.50
- AVG Volume (30 Days)
- ALDX 647.5K
- NNOX 1.5M
- Earning Date
- ALDX 11-06-2025
- NNOX 11-20-2025
- Dividend Yield
- ALDX N/A
- NNOX N/A
- EPS Growth
- ALDX N/A
- NNOX N/A
- EPS
- ALDX N/A
- NNOX N/A
- Revenue
- ALDX N/A
- NNOX $11,886,000.00
- Revenue This Year
- ALDX N/A
- NNOX $20.50
- Revenue Next Year
- ALDX $36.23
- NNOX $64.10
- P/E Ratio
- ALDX N/A
- NNOX N/A
- Revenue Growth
- ALDX N/A
- NNOX 17.36
- 52 Week Low
- ALDX $1.14
- NNOX $3.60
- 52 Week High
- ALDX $7.20
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- ALDX 48.59
- NNOX 48.40
- Support Level
- ALDX $5.13
- NNOX $3.86
- Resistance Level
- ALDX $5.79
- NNOX $4.49
- Average True Range (ATR)
- ALDX 0.28
- NNOX 0.25
- MACD
- ALDX -0.00
- NNOX 0.04
- Stochastic Oscillator
- ALDX 29.10
- NNOX 43.26
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.